δ-Opioid Receptors Expressed by Jurkat T Cells Enhance IL-2 Secretion by Increasing AP-1 Complexes and Activity of the NF-AT/AP-1-Binding Promoter Element

Journal of Immunology

Volumn 159, Issue 11, 1997, Pages 5431-5440

  Hedin, Karen E ^a   Bell, Michael P ^a   Kalli, Kimberly R ^a   Huntoon, Catherine J ^a   Sharp, Burt M ^b   McKean, David J ^a  

^a MAYO CLINIC   (United States)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD28 ANTIGEN; CD3 ANTIGEN; DELTA OPIATE RECEPTOR; DELTORPHIN; DNA BINDING PROTEIN; INTERLEUKIN 2; NUCLEAR PROTEIN; OLIGOPEPTIDE; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR AP 1; TRANSCRIPTION FACTOR NFAT;

ARTICLE; CELL MEMBRANE; CYTOTOXIC T LYMPHOCYTE; HUMAN; IMMUNOLOGY; LEUKEMIA CELL LINE; METABOLISM; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; PROMOTER REGION;

ANTIGENS, CD28; ANTIGENS, CD3; BASE SEQUENCE; CELL MEMBRANE; DNA-BINDING PROTEINS; HUMANS; INTERLEUKIN-2; JURKAT CELLS; MOLECULAR SEQUENCE DATA; NFATC TRANSCRIPTION FACTORS; NUCLEAR PROTEINS; OLIGOPEPTIDES; PROMOTER REGIONS (GENETICS); RECEPTORS, OPIOID, DELTA; T-LYMPHOCYTES, CYTOTOXIC; TRANSCRIPTION FACTOR AP-1; TRANSCRIPTION FACTORS;

EID: 0031297248     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (59)

1. Reisine, T., and G. Pasternak. 1996. Opioid analgesics and antagonists. In The Pharmacological Basis of Therapeutics, 9th Ed. Goodman and Gilman, eds. McGraw-Hill, New York, pp. 521-555.
2. Minami, M., and M. Satoh. 1995. Molecular biology of the opioid receptors: structures, functions and distributions. Neurosci. Res. 23:121.
3. Pasternak, G. W., and K. M. Standifer. 1995. Mapping of opioid receptors using antisense oligodeoxynucleotides: correlating their molecular biology and pharmacology. Trends Pharmacol. Sci. 16:344.
4. Kusnecov, A. W., A. J. Husband, M. G. King, G. Pang, and R. Smith. 1987. In vivo effects of β-endorphin on lymphocyte proliferation and interleukin 2 production. Brain Behav. Immun. 1:88.
5. Raynor, K., H. Kong, Y. Chen, K. Yasuda, L. Yu, G. I. Bell, and T. Reisine. 1994. Pharmacological characterization of the cloned κ-, δ-, and μ-opioid receptors. Mol. Pharmacol. 45:330.
6. o-protein complexes using specific GTP-binding-protein antisera. Biochem. J. 306:71.
7. Roerig, S. C., H. H. Loh, and P. Y. Law. 1992. Identification of three separate guanine nucleotide-binding proteins that interact with the δ-opioid receptor in NG108-15 neuroblastoma X glioma hybrid cells. Mol. Pharmacol. 41:822.
8. i in ND8-47 neuroblastoma X dorsal root ganglion hybrid cells is mediated through G protein-coupled δ-opioid receptors and desensitized by chronic exposure to opioid. J. Neurochem. 65:1612.
9. Jin, W., N. M. Lee, H. H. Loh, and S. A. Thayer. 1992. Dual excitatory and inhibitory effects of opioids on intracellular calcium in neuroblastoma X glioma hybrid NG108-15 cells. Mol. Pharmacol. 42:1083.
10. + T cells. J. Immunol. 157:5324.
11. Sedqi, M., S. Roy, S. Ramakrishnan, and H. H. Loh. 1996. Expression cloning of a full-length cDNA encoding delta opioid receptor from mouse thymocytes. J. Neuroimmunol. 65:167.
12. Chuang, L. F., T. K. Chuang, K. F. Killam, Jr., A. J. Chuang, H. Kung, L. Yu, and R. Y. Chuang. 1994. Delta opioid receptor gene expression in lymphocytes. Biochem. Biophys. Res. Commun. 202:1291.
13. Wick, M. J., S. R. Minnerath, S. Roy, S. Ramakrishnan, and H. H. Loh. 1996. Differential expression of opioid receptor genes in human lymphoid cell lines and peripheral blood lymphocytes. J. Neuroimmunol. 64:29.
14. Belkowski, S. M., J. Zhu, L.-Y. Liu-Chen, T. K. Eisenstein, M. W. Adler, T. J. Rogers. 1995. Sequence of κ-opioid receptor cDNA in the R1.1 thymoma cell line. J. Neuroimmunol. 62:113.
15. Mazumder, S., I. Nath, and M. M. Dhar. 1993. Immunomodulation of human T cell responses with receptor selective enkephalins. Immunol. Lett. 35:33.
16. Linner, K. M., H. E. Quist, and B. M. Sharp. 1995. Met-enkephalin-containing peptides encoded by proenkephalin A mRNA expressed in activated murine thymocytes inhibit thymocyte proliferation. J. Immunol. 154:5049.
17. Wybran, J., T. Appelboom, J.-P. Famaey, and A. Govaerts. 1979. Suggestive evidence for receptors for morphine and methionine-enkephalin on normal human blood T lymphocytes. J. Immunol. 123:1068.
18. Carr, D. J. J., and G. R. Klimpel. 1986. Enhancement of the generation of cytotoxic T cells by endogenous opiates. J. Neuroimmunol. 12:75.
19. House, R. V., P. T. Thomas, and H. N. Bhargava. 1996. A comparative study of immunomodulation produced by in vitro exposure to delta opioid receptor agonist peptides. Peptides 17:75.
20. + murine T cells. J. Pharmacol. Exp. Ther. 273: 1105.
21. Madden, J. J., R. M. Donahoe, J. Zwemer-Collins, D. A. Shafer, and A. Falek. 1987. Binding of naloxone to human T lymphocytes. Biochemical Pharmacol. 36:4103.
22. Mehrishi, J. N., and I. H. Mills. 1983. Opiate receptors on lymphocytes and platelets in man. Clin. Immunol. Immunopathol. 27:240.
23. Carr, D. J. J., B. R. DeCosta, C.-H. Kim, A. E. Jacobson, K. L. Bost, K. C. Rice, and J. E. Blalock. 1990. Anti-opioid receptor antibody recognition of a binding site on brain and leukocyte opioid receptors. Neuroendocrinology 51:552.
24. Carr, D. J. J., C.-H. Kim, B. DeCosta, A. E. Jacobson, K. C. Rice, and J. E. Blalock. 1988. Evidence for a δ-class opioid receptor on cells of the immune system. Cell. Immunol. 116:44.
25. Sibinga, N. E. S., and A. Goldstein. 1988. Opioid peptides and opioid receptors in cells of the immune system. Annu. Rev. Immunol. 6:219.
26. Jain, J., C. Loh, and A. Rao. 1995. Transcriptional regulation of the IL-2 gene. Curr. Opin. Immunol. 7:333.
27. Rudd, C. E. 1996. Upstream-downstream: CD28 cosignaling pathways and T cell function. Immunity 4:527.
28. Sharpe, A. H. 1995. Analysis of lymphocyte costimulation in vivo using transgenic and "knockout" mice. Curr. Opin. Immunol. 7:389.
29. Mueller, D. L., and M. K. Jenkins. 1995. Molecular mechanisms underlying function T-cell unresponsiveness. Curr. Opin. Immunol. 7:375.
30. Weiss, A., and D. R. Littman. 1994. Signal transduction by lymphocyte antigen receptors. Cell 76:263.
31. O'Garra, A., and K. Murphy. 1994. Role of cytokines in determining T-lymphocyte function. Curr. Opin. Immunol. 6:458.
32. Rao, A. 1994. NF-ATp: a transcription factor required for the co-ordinate induction of several cytokine genes. Immunol. Today 15:274.
33. Durand, D. B., J.-P. Shaw, M. R. Bush, R. E. Replogle, R. Belagaje, and G. R. Crabtree. 1988. Characterization of antigen receptor response elements within the interleukin-2 enhancer. Mol. Cell. Biol. 8:1715.
34. Serfling, E., R. Barthelmas, I. Pfeuffer, B. Schenk, S. Zarius, R. Swoboda, F. Mercurio, and M. Karin. 1989. Ubiquitous and lymphocyte-specific factors are involved in the induction of the mouse interleukin 2 gene in T lymphocytes. EMBO J. 8:465.
35. Jain, J., V. E. Valge-Archer, and A. Rao. 1992. Analysis of the AP-1 sites in the IL-2 promoter. J. Immunol. 148:1240.
36. Jain, J., V. E. Valge-Archer, A. J. Sinskey, and A. Rao. 1992. The AP-1 site at -150 bp but not the NF-κB site, is likely to represent the major target of protein kinase C in the interleukin-2 promoter. J. Exp. Med 175:853.
37. Fujita, T., H. Shibuya, T. Ohashi, K. Yamanishi, and T. Taniguchi. 1986. Regulation of human interleukin-2 gene: functional DNA sequences in the 5′ flanking region for the gene expression in activated T lymphocytes. Cell 46:401.
38. Sharp, B. M., N. A. Shahabi, W. Heagy, K. McAllen, M. Bell, C. Huntoon, and D. J. McKean. 1996. Dual signal transduction through delta opioid receptors in a transfected human T-cell line. Proc. Natl. Acad. Sci. USA 93:8294.
39. McKean, D. J., C. Huntoon, and M. Bell. 1994. Ligand-induced desensitization of interleukin 1 receptor-initiated intracellular signaling events in T helper lymphocytes. J. Exp. Med. 180:1321.
40. Ho, S. N., R. T. Abraham, S. Gillis, and D. J. McKean. 1987. Differential bioassay of interleukin 2 and interleukin 4. J. Immunol. Methods 98:99.
41. Novak, T. J., P. M. White, and E. V. Rothenberg. 1990. Regulatory anatomy of the murine interleukin-2 gene. Nucleic Acids Res. 18:4523.
42. O'Keefe, S. J., J. Tamura, R. L. Kincaid, M. J. Tocci, and E. A. O'Neill. 1992. FK-506- and CsA-sensitive activation of the interleukin-2 promoter by calcineurin. Nature 357:692.
43. fyn-deficient T lymphocytes. Immunology 84:183.
44. 2+ indicators with greatly improved fluorescence properties. J. Biol. Chem. 260: 3440.
45. Rabinovitch, P. S., C. H. June, A. Grossmann, and J. A. Ledbetter. 1986. Heterogeneity among T cells in intracellular free calcium responses after mitogen stimulation with PHA or anti-CD3: simultaneous use of indo-1 and immunofluorescence with flow cytometry. J. Immunol. 137:952.
46. Dignam, J. D., R. M. Liebovitz, and R. G. Roeder. 1983. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res. 11:1475.
47. Thompson, C. B., C.-Y. Wang, I.-C. Ho, P. R. Bohjanen, B. Petryniak, C. H. June, S. Miesfeldt, L. Zhang, G. J. Nable, B. Karpinski, and J. M. Leiden. 1992. cis-acting sequences required for inducible interleukin-2 enhancer function bind a novel Els-related protein, Elf-1. Mol. Cell. Biol. 12:1043.
48. Zhang, L., and G. J. Nabel. 1994. Positive and negative regulation of IL-2 gene expression: role of multiple regulatory sites. Cytokine 6:221.
49. 40. Science 254:558.
50. Pei, G., B. L. Kieffer, R. J. Lefkowitz, and N. J. Freedman. 1995. Agonist-dependent phosphorylation of the mouse δ-opioid receptor: involvement of G protein-coupled receptor kinases but not protein kinase C. Mol. Pharmacol. 48: 173.
51. Jain, J., P. G. McCaffrey, V. E. Valge-Archer, and A. Rao. 1992. Nuclear factor of activated T cells contains Fos and Jun. Nature 356:801.
52. Chen, L., M. G. Oakley, J. N. M. Glover, J. Jain, P. B. Dervan, P. G. Hogan, A. Rao, and G. L. Verdine. 1995. Only one of the two DNA-bound orientations of AP-1 found in solution cooperates with NF-ATp. Curr. Biol. 5:882.
53. Yaseen, N. R., J. Park, T. Kerppola, T. Curran, and S. Sharma. 1994. A central role for fos and in human B- and T-cell NF-AT (nuclear factor of activated T cells): an acidic region is required for in vitro assembly. Mol. Cell. Biol. 14:6886.
54. Ho, I.-C., M. R. Hodge, J. W. Rooney, and L. H. Glimcher. 1996. The protooncogene c-maf is responsible for tissue-specific expression of interleukin-4. Cell 85:973.
55. Luo, C., E. Burgeon, J. A. Carew, P. G. McCaffrey, T. M. Badalian, W. S. Lane, P. G. Hogan, and A. Rao. 1996. Recombinant NF-AT1 (NF-ATp) is regulated by calcineurin in T cells and mediates transcription of several cytokine genes. Mol. Cell. Biol. 16:3955.
56. Ho, A. M., J. Jain, A. Rao, and P. G. Hogan. 1994. Expression of the transcription factor NF-ATp in a neuronal cell line and in the murine nervous system. J. Biol. Chem. 269:28181.
57. Nestler, E. J., B. T. Hope, and K. L. Widnell. 1993. Drug addiction: a model for the molecular basis of neural plasticity. Neuron 11:995.
58. Ochi, Y., T. Koizumi, S. Kobayashi, J. Phuchareon, M. Hatano, M. Takada, Y. Tomita, and T. Tokuhisa. 1994. Analysis of IL-2 gene regulation in c-fos transgenic mice. J. Immunol. 153:3485.
59. Bacon, K. B., B. A. Premack, P. Gardner, and T. J. Schall. 1995. Activation of dual T cell signaling pathways by the chemokine RANTES. Science 269:1727.